Michael F III Marino
CIK 1502700 · See Remarks · last filed 2025-06-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.44M
Companies
4
Total Filings
48
Lifetime Open-Market Net
-$166.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NAMSW | See Remarks | 55,000 | $19.38 | $1.07M | $0 | 1 | 2025-06-03 |
| OptiNose, Inc. (OPTN) Delisted | Chief Legal Officer & Corp Sec | 0 | $9.60 | $0 | -$166.9K | 35 | 2025-05-21 |
| Fibrocell Science, Inc. (FCSC) Delisted | SVP and General Counsel | — | — | — | $0 | 2 | 2016-03-02 |
| PATH | VP and General Counsel | 194,484 | $12.19 | $2.37M | $0 | 4 | 2013-01-22 |
Recent Filings · Page 3 of 5
48 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-03-20 | OptiNose, Inc. (OPTN) Delisted | Mixed | −1,155 | -$8.9K | EDGAR |
| 2023-03-10 | OptiNose, Inc. (OPTN) Delisted | Grant (A) | +154,375 | $0 | EDGAR |
| 2023-01-17 | OptiNose, Inc. (OPTN) Delisted | Sell (S) | −5,241 | -$9.3K | EDGAR |
| 2022-12-19 | OptiNose, Inc. (OPTN) Delisted | Mixed | +1,066 | -$4.6K | EDGAR |
| 2022-09-20 | OptiNose, Inc. (OPTN) Delisted | Mixed | +1,082 | -$9.7K | EDGAR |
| 2022-06-17 | OptiNose, Inc. (OPTN) Delisted | Mixed | +19,741 | -$37.7K | EDGAR |
| 2022-03-17 | OptiNose, Inc. (OPTN) Delisted | Sell (S) | −4,617 | -$9.7K | EDGAR |
| 2022-01-12 | OptiNose, Inc. (OPTN) Delisted | Grant (A) | +56,730 | $0 | EDGAR |
| 2021-12-17 | OptiNose, Inc. (OPTN) Delisted | Sell (S) | −580 | -$951 | EDGAR |
| 2021-09-17 | OptiNose, Inc. (OPTN) Delisted | Sell (S) | −578 | -$1.6K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.